IMPACT OF SUCCESSFUL TREATMENT OF HCV ON GLYCEMIC CONTROL IN TYPE 2 DIABETES PATIENTS
OBJECTIVE: HCV infection is more common among adults with type 2 diabetes and possibly it can affect the glycemic control in patients with diabetes. This study was conducted to find whether eradication of CHC infection with direct acting antiviral (DAA) agents is associated with good glycemic control...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Faisalabad
2019-09-01
|
Series: | Journal of University Medical & Dental College |
Subjects: | |
Online Access: | http://jumdc.com/index.php/jumdc/article/view/6 |
_version_ | 1818778751653117952 |
---|---|
author | Muhammad Saeed Akhter Maqsood Ahmad Muhammad Irfan Mubarak Ali Anjum Muhammad Wasif Baig Hooria Amer |
author_facet | Muhammad Saeed Akhter Maqsood Ahmad Muhammad Irfan Mubarak Ali Anjum Muhammad Wasif Baig Hooria Amer |
author_sort | Muhammad Saeed Akhter |
collection | DOAJ |
description | OBJECTIVE: HCV infection is more common among adults with type 2 diabetes and possibly it can affect the glycemic control in patients with diabetes. This study was conducted to find whether eradication of CHC infection with direct acting antiviral (DAA) agents is associated with good glycemic control in patients with type 2 diabetes or otherwise.
MATERIAL AND METHODS: Among 545 patients with diabetes who were treated with DAA (Interferon & Ribavirin free regimen) for chronic HCV infection, were included in the study. Changes in average (HbA1c) levels and use of ant diabetic medication 6 months before and after DAA treatment were compared between patients who achieved sustained virologic response (SVR) and those who did not achieve SVR.
RESULTS: In patients with high base line HbA1c, the drop in HbA1c in reference to DAA treatment was greater in those who achieved SVR (1.99%) in comparison to those who did not (1.70%) (Adjusted mean difference 0.29, p=0.02). The doses of anti diabetic agents decreased more in subjects who achieved SVR in comparison to those who met treatment failure. This was evident for those who were using Insulin for control of their diabetes, which dropped significantly from 46.4% to 41.3% in patients achieving SVR compared with a slight increase from 48.7% to 50.2% in those who were in treatment failure group.
CONCLUSION: It is hereby concluded that improved glycemic control is associated with eradication of HCV with DAA based regimens evidenced by decrease in mean HbA1c and decreased insulin as well as oral anti diabetic agents use in SVR achievers. |
first_indexed | 2024-12-18T11:49:42Z |
format | Article |
id | doaj.art-87e149fe8ad24bcbb3bcb5709a3ff5cb |
institution | Directory Open Access Journal |
issn | 2221-7827 2310-5542 |
language | English |
last_indexed | 2024-12-18T11:49:42Z |
publishDate | 2019-09-01 |
publisher | University of Faisalabad |
record_format | Article |
series | Journal of University Medical & Dental College |
spelling | doaj.art-87e149fe8ad24bcbb3bcb5709a3ff5cb2022-12-21T21:09:11ZengUniversity of FaisalabadJournal of University Medical & Dental College2221-78272310-55422019-09-01103IMPACT OF SUCCESSFUL TREATMENT OF HCV ON GLYCEMIC CONTROL IN TYPE 2 DIABETES PATIENTSMuhammad Saeed AkhterMaqsood AhmadMuhammad IrfanMubarak Ali AnjumMuhammad Wasif BaigHooria AmerOBJECTIVE: HCV infection is more common among adults with type 2 diabetes and possibly it can affect the glycemic control in patients with diabetes. This study was conducted to find whether eradication of CHC infection with direct acting antiviral (DAA) agents is associated with good glycemic control in patients with type 2 diabetes or otherwise. MATERIAL AND METHODS: Among 545 patients with diabetes who were treated with DAA (Interferon & Ribavirin free regimen) for chronic HCV infection, were included in the study. Changes in average (HbA1c) levels and use of ant diabetic medication 6 months before and after DAA treatment were compared between patients who achieved sustained virologic response (SVR) and those who did not achieve SVR. RESULTS: In patients with high base line HbA1c, the drop in HbA1c in reference to DAA treatment was greater in those who achieved SVR (1.99%) in comparison to those who did not (1.70%) (Adjusted mean difference 0.29, p=0.02). The doses of anti diabetic agents decreased more in subjects who achieved SVR in comparison to those who met treatment failure. This was evident for those who were using Insulin for control of their diabetes, which dropped significantly from 46.4% to 41.3% in patients achieving SVR compared with a slight increase from 48.7% to 50.2% in those who were in treatment failure group. CONCLUSION: It is hereby concluded that improved glycemic control is associated with eradication of HCV with DAA based regimens evidenced by decrease in mean HbA1c and decreased insulin as well as oral anti diabetic agents use in SVR achievers.http://jumdc.com/index.php/jumdc/article/view/6HCV, Glycemic, Diabetes patients |
spellingShingle | Muhammad Saeed Akhter Maqsood Ahmad Muhammad Irfan Mubarak Ali Anjum Muhammad Wasif Baig Hooria Amer IMPACT OF SUCCESSFUL TREATMENT OF HCV ON GLYCEMIC CONTROL IN TYPE 2 DIABETES PATIENTS Journal of University Medical & Dental College HCV, Glycemic, Diabetes patients |
title | IMPACT OF SUCCESSFUL TREATMENT OF HCV ON GLYCEMIC CONTROL IN TYPE 2 DIABETES PATIENTS |
title_full | IMPACT OF SUCCESSFUL TREATMENT OF HCV ON GLYCEMIC CONTROL IN TYPE 2 DIABETES PATIENTS |
title_fullStr | IMPACT OF SUCCESSFUL TREATMENT OF HCV ON GLYCEMIC CONTROL IN TYPE 2 DIABETES PATIENTS |
title_full_unstemmed | IMPACT OF SUCCESSFUL TREATMENT OF HCV ON GLYCEMIC CONTROL IN TYPE 2 DIABETES PATIENTS |
title_short | IMPACT OF SUCCESSFUL TREATMENT OF HCV ON GLYCEMIC CONTROL IN TYPE 2 DIABETES PATIENTS |
title_sort | impact of successful treatment of hcv on glycemic control in type 2 diabetes patients |
topic | HCV, Glycemic, Diabetes patients |
url | http://jumdc.com/index.php/jumdc/article/view/6 |
work_keys_str_mv | AT muhammadsaeedakhter impactofsuccessfultreatmentofhcvonglycemiccontrolintype2diabetespatients AT maqsoodahmad impactofsuccessfultreatmentofhcvonglycemiccontrolintype2diabetespatients AT muhammadirfan impactofsuccessfultreatmentofhcvonglycemiccontrolintype2diabetespatients AT mubarakalianjum impactofsuccessfultreatmentofhcvonglycemiccontrolintype2diabetespatients AT muhammadwasifbaig impactofsuccessfultreatmentofhcvonglycemiccontrolintype2diabetespatients AT hooriaamer impactofsuccessfultreatmentofhcvonglycemiccontrolintype2diabetespatients |